We then examined the Bcl-2 and Bcl-xL proteins expression in quercetin treated prostate cancer cells, we observed significant decrease of Bcl-2 and Bcl-xL proteins (Fig. 2). The gene discussed is BCL2; the disease is prostate cancer.